Le Lézard
Classified in: Health
Subject: TRI

SafER has announced a Stage 3 clinical trial evaluating the SafER Negative Pressure System reducing aerosol emissions during bronchoscopic procedures


BRANSON, Mo., May 30, 2024 /PRNewswire/ -- Bronchoscopy is known to be an aerosol generating procedure and produce plumes of microscopic particles, some of which may carry infectious airborne organisms, that can then be inhaled by medical personnel in attendance and subsequently pose a high-risk of those medical staff contracting the disease. "Our goal since the beginning of the pandemic has been to create a safer work environment for our friends and colleagues who are exposed to dangerous pathogens when performing aerosol generating procedures, while expanding access to those life-saving procedures for our patients," said SafER Chief Medical Officer, Dr. Rick Blubaugh.

The SafER system is the world's first portable negative pressure system that utilizes HEPA filtration to capture dangerous fugitive emissions at the source ? the patient.  The system has been in use since the pandemic in hospitals, ambulances, and long-term facilities around the country and can be utilized during a variety of procedures including intubation, nebulizer, CPAP or Bi-Level PAP, endoscopy, and sputum or swab collection.

The study is randomized controlled and will take place in a 1,000-bed tertiary facility and is expected to enroll 80 patients over a 3-month period. The goals of the study are to assess the system and the reduction of aerosol emissions produced during bronchoscopic procedures. Results of the study are expected to be announced late this summer.

http://www.safermedicalproducts.com

Contact:
Carl Baker
[email protected]

Photos:
https://www.prlog.org/13022756

Press release distributed by PRLog

SOURCE SafER Medical Products LLC


These press releases may also interest you

at 19:35
IGC Pharma, Inc. ("IGC" or the "Company") , a clinical-stage pharmaceutical company, has announced its financial results for the fiscal year ended March 31, 2024 ("Fiscal 2024"). Full Fiscal Year Highlights In March 2024, the Company announced...

at 18:39
The Hughes Holden Foundation, a nonprofit organization committed to supporting initiatives that improve mental healthcare to marginalized and underserved communities in the U.S., is proud to announce a significant gift to Columbia University....

at 18:21
Product Creation Studio (PCS), a premier provider of engineering and design services, is excited to announce a new partnership with PatchClamp Medtech Inc. (PMI). This collaboration focuses on developing PatchClamp's novel dural repair graft...

at 18:20
The global wearable patch market  size is estimated to grow by USD 7.11 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 13.26%  during the forecast period.  ...

at 18:00
The global flow diversion aneurysm treatment market size is estimated to grow by USD 2.43 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.34%  during the forecast period. The flow diversion aneurysm...

at 18:00
The Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) is honoured to present the Len Marks Pharmacy Advancement Award to the Coutu Family and Distinguished Partner of the Year Award to Mike Dutton of Pharmascience Canada. Sandra...



News published on and distributed by: